TELA Bio (TELA) Share-based Compensation Growth (5y) (2023 - 2026)
TELA Bio (TELA) Share-based Compensation Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.76% |
| Dec 31, 2025 | 7.26% |
| Sep 30, 2025 | 11.95% |
| Jun 30, 2025 | 14.80% |
| Mar 31, 2025 | 301.55% |
| Dec 31, 2024 | 89.39% |
| Sep 30, 2024 | 76.01% |
| Jun 30, 2024 | 79.19% |
| Mar 31, 2024 | 78.98% |
| Dec 31, 2023 | 23.42% |
| Sep 30, 2023 | 86.30% |